Table 5.
Adverse events | PCAIB group | PCA group | p |
---|---|---|---|
Dizziness | 2 (2%) | 7 (15%) | 0.005∗ |
Nausea | 3 (3%) | 5 (10%) | 0.110 |
Vomiting | 2 (2%) | 3 (6%) | 0.327 |
Respiratory depression | 0 | 0 | — |
Skin itching | 0 | 0 | — |
Urine retention | 0 | 0 | — |
Muscle weakness | 0 | — | — |
Numbness | 3 (3%) | — | — |
Hemidiaphragmatic paresis | 0 | — | |
Local hematoma or infection | 0 | — | — |
Categorical variables as number of events (n); Chi-square test was used, events less than 5 were compared with Fisher's exact test, and ∗statistical significance was considered when p < 0.05.
PCAIB: patients with interscalene block in combination with intravenous patient-controlled analgesia.
PCA: patients receiving intravenous patient-controlled analgesia alone without interscalene block.